Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

Clinical trial NCT06171152 · SUSPENDED

Trial details

NCT number: NCT06171152
Sponsor: University of Chicago
Status: SUSPENDED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis Long COVID Long Covid19 Obese Obesity Obesity, Morbid Acute Leukemia in Remission

Start date: 2024-01-26
Primary completion: 2027-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.